These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 33880801)
21. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma. Li Z; Shen L; Li Y; Shen L; Li N Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984 [TBL] [Abstract][Full Text] [Related]
22. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival. Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034 [TBL] [Abstract][Full Text] [Related]
23. Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma. Lin C; Chen Y; Pan J; Lu Q; Ji P; Lin S; Liu C; Lin S; Li M; Zong J BMC Genomics; 2023 Apr; 24(1):221. PubMed ID: 37106442 [TBL] [Abstract][Full Text] [Related]
24. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
25. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma. Liu J; Lu J; Li W BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159 [TBL] [Abstract][Full Text] [Related]
26. Autophagy-Related Signature for Head and Neck Squamous Cell Carcinoma. Li C; Wu ZH; Yuan K Dis Markers; 2020; 2020():8899337. PubMed ID: 33133307 [TBL] [Abstract][Full Text] [Related]
27. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC). Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648 [TBL] [Abstract][Full Text] [Related]
28. Cancer associated fibroblast derived gene signature determines cancer subtypes and prognostic model construction in head and neck squamous cell carcinomas. Wu S; Huang C; Su L; Wong PP; Huang Y; Chen R; Lin P; Ye Y; Song P; Han P; Huang X Cancer Med; 2023 Mar; 12(5):6388-6400. PubMed ID: 36404634 [TBL] [Abstract][Full Text] [Related]
29. The Potential of Oxidative Stress Related Genes as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma. Wang X; Zhou G Comb Chem High Throughput Screen; 2022; 25(11):1952-1965. PubMed ID: 34875987 [TBL] [Abstract][Full Text] [Related]
30. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H Front Immunol; 2022; 13():961695. PubMed ID: 36389709 [TBL] [Abstract][Full Text] [Related]
31. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma. Zhu G; Wang W; Yao H; Li H; Zhang C; Meng Y; Wang J; Zhu M; Zheng H Sci Rep; 2023 Oct; 13(1):18763. PubMed ID: 37907576 [TBL] [Abstract][Full Text] [Related]
32. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis. Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351 [TBL] [Abstract][Full Text] [Related]
33. Comprehensive analysis of matrix metalloproteinases and their inhibitors in head and neck squamous cell carcinoma. Zou M; Zhang C; Sun Y; Wu H; Xiao F; Gao W; Zhao F; Fan X; Wu G Acta Oncol; 2022 Apr; 61(4):505-515. PubMed ID: 34879791 [No Abstract] [Full Text] [Related]
34. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related]
35. Identifying KRT20 as a Potential Key Gene in Lymphatic Metastasis of Head and Neck Squamous Cell Carcinoma. Zhang YF; Huang Q; Huang HY; Ren HL; Zhou L Technol Cancer Res Treat; 2022; 21():15330338221107710. PubMed ID: 35815926 [No Abstract] [Full Text] [Related]
37. Identification of prognostic aging-related genes associated with immunosuppression and inflammation in head and neck squamous cell carcinoma. Yang J; Jiang Q; Liu L; Peng H; Wang Y; Li S; Tang Y; Yu J; Gan R; Liu Z Aging (Albany NY); 2020 Nov; 12(24):25778-25804. PubMed ID: 33232279 [TBL] [Abstract][Full Text] [Related]
38. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with Head and Neck Squamous Cell Carcinoma. Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622 [TBL] [Abstract][Full Text] [Related]
39. Transcriptomic analysis of Porphyromonas gingivalis-infected head and neck cancer cells: Identification of PLAU as a candidate prognostic biomarker. Hamada M; Inaba H; Nishiyama K; Yoshida S; Yura Y; Matsumoto-Nakano M; Uzawa N J Cell Mol Med; 2024 Feb; 28(4):. PubMed ID: 38363001 [TBL] [Abstract][Full Text] [Related]
40. Identification of Immune-Related Prognostic Biomarkers Associated with HPV-Positive Head and Neck Squamous Cell Carcinoma. Chen Y; Nie J; Li X; Fan T; Deng X; Liang D; Song G J Immunol Res; 2021; 2021():6661625. PubMed ID: 33506058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]